|
Company:
|
INSULET CORP (PODD)
|
|
Form Type:
|
4
|
|
Filing Date:
|
11/18/2020
|
|
CIK:
|
0001145197
|
|
Address:
|
100 NAGOG PARK
|
|
City, State, Zip:
|
ACTON, Massachusetts 01720
|
|
Telephone:
|
978-600-7000
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$284.46
|
Change:
3.26 (1.16%)
|
Trade Time:
04:00 PM EST
|
Market Cap:
$18.75B
|
|
|
|
|
|
|
Description of Business
|
|
Insulet Corporation ("we" or the "Company") is primarily engaged in the
development, manufacture and sale of its proprietary Omnipod® System, an
innovative, discreet and easy-to-use continuous insulin delivery system for
people with insulin-dependent diabetes, which we have been selling since 2005.
The Omnipod System consists of the following: the Omnipod Insulin Management
System ("Omnipod") and the Omnipod DASHTM Insulin Management System ("Omnipod
DASH" or "DASH"), our next generation digital mobile Omnipod platform.
There are two primary types of insulin therapy practiced today: multiple daily
injection ("MDI") therapy using syringes or insulin pens; and pump therapy using
insulin pumps. Insulin pumps are used to perform continuous subcutaneous insulin
infusion and typically use a programmable device and an infusion set to
administer insulin into the person's body.
|
|
|
|